Precigen Inc
Save
–
Market cap
–
Current P/E
7.22x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Precigen, Inc. operates as a discovery and clinical stage biopharmaceutical company that develops gene and cell therapies using precision technology to target diseases in therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company, through its technologies, enables to find solutions for biotherapeutics. The company operates as an engine progressing a preclinical and clinical pipeline of therapies toward clinical proof-of-concept and commercialization.
Similar securities
Based on sector and market capitalization
Report issue